Additional data from the BE BOLD trial supporting bimekizumab over risankizumab are slated for a future medical conference.
Peter Nash, MBBS, FRACP
Advertisement
Peter Nash, MBBS, is a professor of the School of Medicine at Griffith University in Queensland, Australia.
Articles by Peter Nash, MBBS, FRACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement